Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Revenue

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹4,430 Cr₹3,999 Cr₹2,707 Cr₹1,945 Cr₹2,052 Cr

What is the latest Revenue of NATCO PHARMA ?

The latest Revenue ratio of NATCO PHARMA is ₹4,430 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹4,430 Cr
Mar2024₹3,999 Cr
Mar2023₹2,707 Cr
Mar2022₹1,945 Cr
Mar2021₹2,052 Cr

How is Revenue of NATCO PHARMA Trending?

Years Revenue % Change
Mar2025 ₹4,430 Cr
10.77
Mar2024 ₹3,999 Cr
47.72
Mar2023 ₹2,707 Cr
39.20
Mar2022 ₹1,945 Cr
-5.23
Mar2021 ₹2,052 Cr -

Compare Revenue of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,571.8 Cr -8.2% -4% -33.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,037.0 Cr -3% -3.6% -4.9% Stock Analytics
DIVIS LABORATORIES ₹170,795.0 Cr -3.1% 0.1% 11.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,332.0 Cr -3.7% 4% 18.8% Stock Analytics
CIPLA ₹116,933.0 Cr -1.3% -4.6% -1.5% Stock Analytics
DR REDDYS LABORATORIES ₹99,350.2 Cr -4.2% -7% -11.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-8.2%

-4%

-33.3%

SENSEX

-1.7%

-1.4%

7%


You may also like the below Video Courses